 "From its highs over the past month, the stock of Procter & Gamble Hygiene and Healthcare is down 7 per cent before recovering this week P&G")
Procter & Gamble Health share price today
Shares of Procter & Gamble Health hit a four-year high at ₹6,475, as they rallied 10 per cent on the BSE in Friday’s intra-day trade in an otherwise weak market after the company reported strong earnings for the quarter ended June 2025 (Q1FY26).
The stock price of the pharmaceutical company was quoting at its lowest level since April 2021. It had hit a record high of ₹7,499.95 on February 11, 2021.
At 02:34 PM; Procter & Gamble Health was trading 7 per cent higher at ₹6,312.10, as compared to 0.40 per cent decline in the BSE Sensex.
Q1 results - Procter & Gamble Health
Procter & Gamble Health delivered a strong performance with sales of ₹333 crore, up 20 per cent against a year ago, owing to broad-based growth in domestic and exports business. Profit after tax (PAT) stood at ₹66 crore, against ₹17 crore a year ago, due to strong sales growth and one-time impact of impairment in the base period.
Commenting on the performance, Milind Thatte, Managing Director, P&G Health India, said, "We are pleased with the continued momentum and strong start to the Financial Year 2025-26. These results are a reflection of our commitment towards addressing the evolving needs of our consumers and healthcare professionals, via superior brand building and go to market initiatives while improving supply chain capabilities”.
Also Read
 "Stock market")
 "Fancy dividends? Keep an eye on these companies")
 "Two wheelers")
 "Sensex, Nifty, stock brokers")
 "Stocks to watch")
The company's strategy, centered on a focused portfolio of quality, trusted, and highly recommended brands where performance drives brand choice; superiority (across product, package, brand communication, retail execution and value), constructive disruption and an agile accountable organization, is delivering balanced and sustainable growth results, Milind Thatte said.
Opportunities, outlook
The healthcare sector in India has undergone a significant transformation, fueled by substantial investments in infrastructural development. Since 2016, the Indian healthcare industry has witnessed a consistent growth trajectory. The consumer healthcare sector shows promising prospects for the future. The company is well-positioned to sustain and strengthen its position in the market.
About Procter & Gamble Health
Procter & Gamble Health Limited is one of India’s largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion.
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Ambi Pur, Ariel, Gillette, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide, Vicks, and Whisper. P&G operates in approximately 70 countries worldwide.
 "VIX VAPOUR RISING, markets crash, sensex")
 "initial public offering, IPO")
 "An office building that houses the Jane Street Group headquarters in New York")
 "The stock of the second-largest electronic manufacturing services (EMS) player by market capitalisation, Kaynes Technology India, is up 10 per cent from its monthly lows. This was on better than expected June quarter performance, strong order flows a")
 "Anand Kamalnayan Pandit, Chairman & Managing Director, Sri Lotus Developers & Realty Limited (Photo: Kamlesh Pednekar)")
